MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations;Apport de l'IRM cérébrale dans une série de 58 cas de malade lupique avec ou sans manifestations neuropsychiatriques

Revue de Medecine Interne

Volumn 25, Issue 1, 2004, Pages 8-15

  Cotton, F ^a   Bouffard Vercelli, J ^a   Hermier, M ^b   Tebib, J ^a   Durand, D Vital ^a   Minh, V A Tran ^a   Rousset, H ^c  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c NONE

Author keywords

Central nervous system; MRI; Systemic lupus erythematosus

Indexed keywords

ARTICLE; ATROPHY; BASAL GANGLION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVALUATION; HUMAN; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MICROEMBOLISM; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 1242273782     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00265-0     Document Type: Article

References (33)

1. Kaposi M. Neue beiträge zur kenntniss des lupus erythematosus. Archiv Dermatol Syphilol. 1872;4-36.
2. Manger K., Manger B., Repp R., Geisselbrecht M., Geiger A., Pfahlberg A., et al. Definition of risk factors for death, end stage renal disease, and thrombo-embolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 61:2002;1065-1070.
3. Hanly J.G., Cassell K., Kisk J.D. Cognitive function in systemic lupus erythematosus: results of a five-year prospective study. Arthritis Rheum. 40:1997;1542-1543.
4. McCune W.J., MacGuire A., Aisen A., Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum. 31:1988;159-166.
5. O'Connor J., Musher D. Central nervous system involvement in systemic lupus erythematosus. A study of 150 cases. Arch Neurol. 14:1966;157-164.
6. Glaser G.H. Collagen disease of the nervous system. Med Clin North Am. 47:1963;1475-1495.
7. Ellis S.G., Verity M.A. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum. 8:1979;212-221.
8. Vermess M., Bernstein R.M., Bydder G.M., Steiner R.E., Young I.R., Hughes G.R. Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr. 7:1983;461-467.
9. Sibbitt W.L., Sibbitt R.R., Griffey R.H., Ceckel C., Bankhurst A.D. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 48:1989;1014-1022.
10. Jacobs L., Kinkel P.R., Costello P.B., Alukal M.K., Kinkel W.R., Green F.A. Central nervous system lupus erythematosus: the value of Magnetic Resonance Imaging. J Rheumatol. 15:1988;601-606.
11. Bosna G.P.T., Rood M.J., Zwinderman A.H., Huizinga T.W.J., Van Buchem M.A. Evidence of central nervous damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum. 1:2000;48-54.
12. Tourbah A., Deschamps R., Stievenart J.L., Lopez A., Iba-Zizen M.T., Lyon-Caen O., et al. Magnetic resonance imaging using flair pulse sequence in white matter diseases. J Neuradiol. 23:1996;217-222.
13. Gonzalez-Crespo M.R., Blanco F.J., Ramos A., Ciruelo E., Mateo I., Lopez Pino M.A., et al. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Br J Rheumatol. 34:1995;1055-1060.
14. Sanna G., Piga M., Terryberry J.W., Peltz M.T., Giagheddu S., Satta L., et al. A. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 9:2000;573-583.
15. Bell C.L., Partington C., Robbins M., Graziano F., Turski P., Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Arthritis Rheum. 34:1991;432-441.
16. Karassa F.B., Ioannidis J.P., Boki K.A., Touloumi G., Argyropoulou M.I., Strigaris K.A., et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J M. 109:2000;628-634.
17. Jarek M.J., West S.G., Baker M.R., Rak K.M. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum. 11:1994;1609-1613.
18. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1997;1725-1734.
19. The American College of Rheumatology nomenclature and cases definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42:1999;599-608.
20. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum. 42:1999;1309-1311.
21. Cotton F., Grivolat S., Hermier M., Puech P., Tran-Minh V.A. Perivascular (Virchow-Robin) spaces: normal and pathological features observed on MRI. Boston ASNR 39th Annual Meeting and Symposium :2001;85.
22. Sze G., de Armond S.J., Brant-Zawadzki M., Davis R.L., Norman D., Hans Newton T. Foci of MRI signal (pseudo lesions) anterior to the frontal horns: histologic correlation of a normal finding. AJR. 147:1986;331-337.
23. Paty D.W. Magnetic resonance imaging in the assessment of disease activity in multiple sclerosis. Can J Neurol Sci. 15:1988;266-272.
24. Hanly J.G., Walsh N.M.G., Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol. 19:1992;732-741.
25. Ishikawa O., Ohnishi K., Miyachi Y., Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging: relationship to anticardiolipid antibody. J Rheumatol. 21:1994;87-90.
26. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol. 29:1989;164-168.
27. Aisen A.M., Gabrielsen T.O., McCune W.J. MR imaging of systemic lupus erythematosus involving the brain. AJR. 144:1985;1027-1031.
28. Levine S.R., Brey R.L., Joseph C.L., Havstad S. Risk of recurrent thrombo-embolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke. 23:(suppl 1):1992;I29-I32.
29. Harris E.N., Gharavi A.E., Asherson R.A., Boey M.L., Hughes G.R.V. Cerebral infarction in systemic lupus erythematosus: association with anticardiolipid antibodies. Clin Exp Rheumatol. 2:1984;47-51.
30. Robbins M.L., Kornguth S.E., Bell C.L., Kalinke T., England D., Turski P., et al. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 31:1988;623-631.
31. Stimmler M.M., Coletti P.M., Quismorio F.P.J. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum. 22:1993;335-349.
32. Killian P.J., Schnapf D.J., Lawless O.J. Computerized axial tomography of central nervous system lupus. Arthritis Rheum. 22:1979;628-629.
33. Bentson J., Reza M., Winter J., Wilson G. Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Tomogr. 2:1978;16-23.